Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Pharming Group NV Leiden (PK) (PHGUF)

Pharming Group NV Leiden (PK)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:PHGUF
DateTimeSourceHeadlineSymbolCompany
15/12/202311:04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PHGUFPharming Group NV Leiden (PK)
13/11/202314:59Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PHGUFPharming Group NV Leiden (PK)
25/09/202315:20Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PHGUFPharming Group NV Leiden (PK)
14/08/202313:31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PHGUFPharming Group NV Leiden (PK)
09/08/202316:24Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PHGUFPharming Group NV Leiden (PK)
18/07/202311:40Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PHGUFPharming Group NV Leiden (PK)
01/06/202311:15Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
11/04/202313:58Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
05/04/202311:57Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)USOTC:PHGUFPharming Group NV Leiden (PK)
27/03/202318:41Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
16/03/202314:39Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
13/03/202311:34Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
13/03/202311:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
21/02/202314:43Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
17/02/202315:41Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
27/10/202211:29Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
02/08/202211:09Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
02/06/202213:32Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
18/05/202217:55Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
26/04/202212:07Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
06/04/202221:15Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)USOTC:PHGUFPharming Group NV Leiden (PK)
06/04/202221:10Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
06/01/202212:03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
04/01/202212:03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
28/10/202121:18Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:PHGUFPharming Group NV Leiden (PK)
28/10/202112:04Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
22/10/202112:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
14/09/202114:00Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
09/08/202121:05Edgar (US Regulatory)Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)USOTC:PHGUFPharming Group NV Leiden (PK)
05/08/202112:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
 Showing the most relevant articles for your search:USOTC:PHGUF